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Abstract
Background: A great amount of data has been accumulated on genetic variations in the human genome, but we still do not
know much about how the genetic variations affect gene function. In particular, little is known about the distribution of
nonsense polymorphisms in human genes despite their drastic effects on gene products.
Methodology/Principal Findings: To detect polymorphisms affecting gene function, we analyzed all publicly available
polymorphisms in a database for single nucleotide polymorphisms (dbSNP build 125) located in the exons of 36,712 known
and predicted protein-coding genes that were defined in an annotation project of all human genes and transcripts (H-InvDB
ver3.8). We found a total of 252,555 single nucleotide polymorphisms (SNPs) and 8,479 insertion and deletions in the
representative transcripts in these genes. The SNPs located in ORFs include 40,484 synonymous and 53,754 nonsynonymous
SNPs, and 1,258 SNPs that were predicted to be nonsense SNPs or read-through SNPs. We estimated the density of
nonsense SNPs to be 0.85610
23 per site, which is lower than that of nonsynonymous SNPs (2.1610
23 per site). On average,
nonsense SNPs were located 250 codons upstream of the original termination codon, with the substitution occurring most
frequently at the first codon position. Of the nonsense SNPs, 581 were predicted to cause nonsense-mediated decay (NMD)
of transcripts that would prevent translation. We found that nonsense SNPs causing NMD were more common in genes
involving kinase activity and transport. The remaining 602 nonsense SNPs are predicted to produce truncated polypeptides,
with an average truncation of 75 amino acids. In addition, 110 read-through SNPs at termination codons were detected.
Conclusion/Significance: Our comprehensive exploration of nonsense polymorphisms showed that nonsense SNPs exist at
a lower density than nonsynonymous SNPs, suggesting that nonsense mutations have more severe effects than amino acid
changes. The correspondence of nonsense SNPs to known pathological variants suggests that phenotypic effects of
nonsense SNPs have been reported for only a small fraction of nonsense SNPs, and that nonsense SNPs causing NMD are
more likely to be involved in phenotypic variations. These nonsense SNPs may include pathological variants that have not
yet been reported. These data are available from Transcript View of H-InvDB and VarySysDB (http://h-invitational.jp/
varygene/).
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Introduction
Genetic variations in the human genome are maintained by a
balance of mutation, selection and random genetic drift. Some of
the polymorphisms cause phenotypic variations and diseases.
Therefore, many studies have attempted to identify causative
variants of genetic diseases and the relationships between genetic
variations and phenotypic effects. Genetic variations within linked
loci are inherited to the same gamete. Based on the linkage of
genetic variations, loci that contain disease-causing genes have
been mapped by using polymorphic markers. At present, about 14
million clusters of genetic polymorphisms have been identified in
the human genome [1]. On average, two haploid genomes are
estimated to differ by one single nucleotide polymorphism (SNP) in
every 1200–1500 bp [2]. SNPs have been recently used to conduct
genome-wide association studies to find genomic regions that are
susceptible to diseases and phenotypic variations [3,4,5,6]. In this
approach, usually, causative polymorphisms for diseases or
phenotypic variations are identified after the identification of
susceptible genomic regions by using SNP markers. Such SNPs are
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polymorphisms and phenotypic variations were examined to
identify genomic regions where causative genes are located.
Another approach in finding pathological variants is to extract
polymorphisms that alter amino acids in functional genes or affect
gene expression or splicing, using a comprehensive set of functional
elements of the human genome. Several studies have analyzed
nonsynonymous SNPs to predict pathological variants [7,8,9,
10,11,12,13,14]. A large number of nonsynonymous SNPs also
have been examined for associations with diseases[15,16].
Although many pathological mutations have been identified
[17,18], the number of such variants is small compared to the
number of known polymorphisms, and it is still unclear which
polymorphisms have biological effects. In a study of consanguin-
eous marriage [19], it was estimated that each person has
deleterious alleles that are equivalent to a few lethal genes. Gene-
centric SNP surveys have shown that the ratio of nonsynonymous
to synonymous SNPs is significantly higher in the low frequency
class than in the common frequency class [20,21,22]. These results
suggest that a large fraction of the low frequency nonsynonymous
SNPs are deleterious. To understand the molecular basis of the
effects of human genetic variations on phenotypic variations, a
prediction analysis of possible effects of polymorphisms on gene
function in all human genes appears to be needed.
In this study, to detect polymorphisms affecting gene function,
we analyzed all publicly available polymorphisms in the Single
Nucleotide Polymorphism Database (dbSNP) (build 125) in the
exons of all 36,712 protein-coding genes that were defined in an
annotation project of all human genes and transcripts (H-InvDB
ver3.8)[23,24]. In summary with representative transcripts (one
transcript from one gene), we detected 53,754 nonsynonymous
SNPs and 1,417 SNPs causing changes between amino acids and
stop codons. Among possible point mutations in ORFs, nonsense
mutations cause the most drastic changes of gene products. In fact,
several reports have shown that nonsense mutations cause genetic
diseases [25,26,27,28]. Truncation of a polypeptide by a
premature termination codon causes a drastic change in the gene
product. Furthermore, it is known that a nonsense mutation can
cause decay of mRNA resulting in the absence of the gene
product. This process, called ‘nonsense-mediated decay (NMD)’
limits the synthesis of abnormal proteins[29,30,31]. On the other
hand, the loss of a termination codon in a transcript also appears
to cause decay of mRNA (referred to as non-stop decay) and thus
to prevent translation[32,33]. In spite of the severe effects of
nonsense mutations, the distribution of nonsense SNPs in human
genes is little understood. In this study, we examined the density of
nonsense SNPs in human genes, and showed that nonsense SNPs
exist at a lower density than nonsynonymous SNPs, possibly due to
the more severe effects of premature stop codons than amino acid
changes. About a half of nonsense SNPs are predicted to cause
NMD. The correspondence between known pathological variants
and nonsense SNPs suggests that nonsense SNPs causing NMD
are more likely to be involved in phenotypic variations.
Results
Selection and classification of polymorphisms in exon
regions
We analyzed 9,235,997 polymorphisms (dbSNP build 125) in
the human genome with exon positions and predicted ORFs that
were revealed in our annotation project of human genes (H-
InvDB) (Figure 1). In all of the 36,712 protein-coding loci in the
genome, we detected 252,555 SNPs and 8,479 insertions and
deletions (indels) that exist in exon regions of the representative
transcript (one transcript from one gene) (Table 1). The
polymorphisms in the exon regions were further classified
according to the predicted ORFs. We detected 96,164 SNPs
within the ORFs, 51,881 SNPs in the 59UTR regions and 104,510
SNPs in the 39UTR regions. Among the SNPs in the ORFs,
40,484 were synonymous and 53,754 were nonsynonymous
(Further analyses of nonsynonymous SNPs are described in
Results S1.). Most of the indels were detected in the UTR regions.
The ORF regions contained 1,258 SNPs that cause changes
between amino acids and stop codons (Table S1). Of the 1,258
SNPs, 1,183 SNPs were regarded as nonsense SNPs, while 75 were
found to have stop codons as ancestral alleles. We also detected
247 SNPs at termination codon sites, 88 of which were
synonymous. The remaining 159 SNPs were changes between
stop codons and amino acids. After checking ancestral alleles, 110
of the 159 SNPs were inferred to be read-through SNPs, while the
other 49 were inferred to changes to stop codons.
Distribution of polymorphisms in exon regions
Densities of polymorphisms were estimated for 23,717 genes
whose functions are clearly defined or suggested (similarity
category I–III, see Materials and Methods) and genes annotated
as conserved hypothetical proteins (similarity category IV). To
estimate the densities of SNPs for synonymous, nonsynonymous
and nonsense SNPs in the ORFs, we calculated the numbers of
potential nucleotide sites for synonymous, nonsynonymous and
nonsense mutations in the coding regions. The fractions of sites
(%) in the coding regions for synonymous, nonsynonymous, and
nonsense mutations were estimated to be 28.5%, 68.1%, and
3.4%, respectively. Of the three types of SNPs, synonymous SNPs
had the highest density, 4.1610
23 per synonymous site, in ORFs
(Table 2). The estimated density of nonsynonymous SNP was
2.1610
23 per site (Table 2). The lower density of nonsynonymous
SNPs compared with synonymous SNPs (51%) is due to the
functional constraint of amino acid changes, and is in agreement
with previous studies [20,22,34]. However, the ratio of the
numbers of nonsynonymous SNPs to synonymous SNPs per site is
higher in this study compared with previous studies (32–34%)
[20,21,22], which they focused on specific populations. The higher
ratio of nonsynonymous SNPs in this study may be due to the fact
that our study is based on pooled data from various populations
world wide. This study includes many nonsynonymous SNPs that
exist in relatively lower frequencies and are likely to be more
population-specific in comparison to synonymous SNPs [20].
Among random nucleotide mutations in ORFs, 3.4% would be
expected to be nonsense mutations; however, the distribution of
nonsense SNPs has not been evaluated or reported. The density of
nonsense SNPs was estimated to be 0.85610
23 per site (Table 3),
which is only 21% of the density of synonymous SNPs, and 40% of
the density of nonsynonymous SNPs. The reason for the lowest
density of nonsense SNPs may be that premature stop codons have
more severe effects than amino acid changes.
In the exons of the 36,712 loci, 8479 indels were detected, and
1,532 of them were found in ORFs. Among the latter, 1,331 are
expected to cause frame shifts, resulting in drastic changes of
proteins. The density of indels in ORFs was much lower than in
the UTR regions (Table 4). The lower density of indels in the
59UTRs than in the 39UTRs suggests that functional constraint for
insertions and deletions is higher in the 59UTR regions than in the
39UTR regions.
Nonsense SNPs
We examined the patterns and the positions of the nonsense
SNPs. There are 23 possible ways to change codons into stop
Distribution of Nonsense SNPs
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positions, respectively), and all 23 were found (Table 5). Nonsense
SNPs were more frequent at the first codon position than at the
second and third positions (p,0.005, chi-square test). The most
frequent type of nonsense mutation is the change from CGA to
TGA (Table 5), which is a transitional change at CpG mutation
hotspots [35]. However, it is notable that there were frequent
transversional mutations such as GAA to TAA and GAG to TAG.
Our analyses of nonsense polymorphisms revealed that changes
between hydrophilic amino acids and termination codons by
nucleotide changes at the first codon positions were very frequent.
We examined the positions of 1,183 nonsense polymorphisms in
the coding regions. On average, nonsense SNPs were located at
250 codons upstream of the original termination codons. To
predict whether a nonsense mutation causes nonsense-mediated
decay (NMD) of mRNA, we examined the locations of nonsense
SNPs in the exon-intron structure of the genes (Table 6). As a
result, of the 1183 nonsense SNPs, 581 were predicted to cause
NMD, and thus to prevent translation. The other 602 cases of
nonsense SNPs were predicted to result in truncated proteins. For
the cases that truncated proteins are produced, the average
truncation was estimated to be 75 amino acids.
To see which of these nonsense SNPs were known pathological
mutations, we compared them with allelic variants in the Online
Mendelian Inheritance in Man (OMIM) database. Only eight of
1,183 nonsense SNPs (rs17602729 in AMPD1, rs283413 in
ADH1C, rs10250779 in PGAM2, rs17215500 in KCNQ1,
rs497116 in CASP12, rs2228325 in ACTN3, rs3092891 in RB1
and rs28989186 in BUB1B) matched the variants in the OMIM
database that are known variants with phenotypic variations
(Table 7). This low value suggests that the biological effects of most
nonsense SNPs have not yet been reported. Interestingly, each of
the eight cases that matched known pathological variants was
predicted to cause NMD (Table 7).
SNPs that cause read-though of the original termination
codon
Among the 247 SNPs at termination codon sites, 119 SNP-
mRNA pairs were found to be read-through mutations. If the
allele having the stop codon is the ancestral type, the SNP is
Table 1. SNPs and indels in exon, intron and other genomic
regions.
Exon Intron Other genomic regions
SNPs 249,182 3,332,537 5,209,127
Indels 9,742 185,761 249,648
Polymorphisms mapped on single positions were analyzed with 36,712 protein-
coding genes.
doi:10.1371/journal.pone.0003393.t001
Figure 1. Analysis of polymorphisms with gene structure. Top: Scheme of analysis pipeline of polymorphisms with gene structure. Bottom:
Screen shots taken from ‘Transcript View’ in H-InvDB that show classified SNPs and their positions (blue bars) in the CASP12 gene.
doi:10.1371/journal.pone.0003393.g001
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However, an extended polypeptide would be expected only if there
is an additional termination codon downstream. For 108 SNP-
mRNA pairs, an additional termination codon was found in the
39UTR region. The average extension was estimated to be 29
amino acids. Interestingly, we found five SNP-mRNA pairs that
have no stop codons in the 39UTR at all (The remaining six SNP-
mRNA pairs do not have 39UTR regions). For example, the T-to-C
substitution(rs15941)intheDDR2gene(X74764)ispredictedtobea
read-through mutation (from TAG to CGA), and the transcript has
no other stop codon in the 39UTR region. The frequency of this
SNP is unknown (it is monomorphic in the four populations in
HapMap project [4]). However, if this polymorphism really exists,
transcripts having this read-through mutation would not produce a
protein. Another example is the T-to-C substitution (rs17850833) in
Table 2. Classified SNPs in exon regions.
Region Effects on translation Genes in category I–IV
a All protein-coding genes
b
59UTR 23454 [3.3610
23/site]
c 51881
ORF Total 85233 [2.7610
23/site] 96164
Synonymous 37484 [4.1610
23 /site] 40484
Nonsynonymous 46261 [2.1610
23 /site] 53754
AA«Ter
d 938 1258
Unclassified
e 398 421
Stop codon Total 152 247
Synonymous 63 88
Ter«AA
d 89 159
39UTR 69691 [3.3610
23/site] 104510
Total 178378 252555
aRepresentative transcripts in 23,717 genes whose function were defined or suggested (similarity category I–III) and genes annotated as conserved hypothetical
proteins (similarity category IV).
bRepresentative transcripts in all protein-coding genes (36,712) including genes in similarity category I–IV plus similarity category V–VII (hypothetical protein,
hypothetical short protein, and pseudogene candidate, respectively).
cDensities of polymorphisms are shown in brackets as average number of polymorphisms per site. The average lengths of the 59UTR, ORF and 39UTR regions in 23717
genes were 303.9 bp, 1343.5 bp, and 877.6 bp, respectively. The densities of SNPs for synonymous, nonsynonymous and nonsense SNPs in ORFs were calculated based
on the numbers of potential nucleotide sites for synonymous, nonsynonymous and nonsense mutations in coding regions. The density of nonsense SNPs is shown in
Table 3.
dSNPs causing changes between amino acids and stop codons.
doi:10.1371/journal.pone.0003393.t002
Table 4. Insertions and deletions in exon regions.
Genes in category I–IV
a All protein-coding genes
a
59UTR 785 [0.11610
23]
b 2005
ORF 1120 [0.035610
23] 1532
39UTR 3323 [0.16610
23] 4942
Total 5225
c 8479
aThese two gene sets are the same as Table 2.
bDensities of polymorphisms are shown in brackets as average number of
polymorphisms per site.
cThree indels were located on both of ORF and UTR.
doi:10.1371/journal.pone.0003393.t004
Table 5. Frequency of each type of codon change for
nonsense SNPs.
TAA TAG TGA Total
AaaRTaa 33 AagRTag 31 AgaRTga 20
1st CaaRTaa 62 CagRTag 162 CgaRTga 203 748*
GaaRTaa 80 GagRTag 125 GgaRTga 32
tCaRtAa 27 tCgRtAg 19 tCaRtGa 25
2nd tGgRtAg 80 200
tTaRtAa 18 tTgRtAg 18 tTaRtGa 13
taCRtaA 25 taCRtaG 25 tgCRtgA 22
3rd tgGRtgA 85 235
taTRtaA 19 taTRtaG 27 tgTRtgA 32
Total 264 487 432 1183
Bold letters show nucleotide changes by transition.
*P,0.005 by chi-square test.
doi:10.1371/journal.pone.0003393.t005
Table 3. SNPs causing changes between amino acids and
stop codons.
Region
Effects on
translation
Genes in category
I–IV
a
All protein-
coding genes
a
ORF Nonsense 910 [0.85610
23/site]
d 1183
Read-through
b 28 75
Stop codon Read-through 67 110
Nonsense
c 22 49
aThese two gene sets are the same as Table 2.
bPossible read-through SNPs in which alleles coding stop codons were ancestral
type. This may be due to existence of shorter ORFs in the ancestral population.
cPossible nonsense SNPs in which alleles coding stop codons were derived
alleles. This may be due to existence of longer ORFs in the ancestral
population.
dThe densities of nonsense SNPs in ORFs were calculated based on the numbers
of potential nucleotide sites for nonsense mutations in coding regions.
doi:10.1371/journal.pone.0003393.t003
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CGA resulting in a change to arginine.
Functional bias of genes having nonsense SNPs
To see whether there is any functional bias in genes having
nonsense SNPs, we examined the frequent biological terms in the
genes having nonsense SNPs. We classified the genes having
nonsense SNPs into two categories: genes with nonsense SNPs that
are predicted to cause NMD and genes with nonsense SNPs that
are not predicted to cause NMD. For genes having nonsense SNPs
that would cause NMD (Table 8), the molecular functions that are
most overrepresented included phosphorylation, ATP binding,
iron/calcium ion binding, nucleotide/RNA binding and trans-
porter activity. The localization of these genes was also biased to
the cell membrane and the proteinaceous extracellular matrix. On
the other hand, the genes having nonsense SNPs predicted to not
cause NMD showed less bias in biological function (Table 9).
Table 6. Nonsense SNPs and prediction of NMD.
Predicted to
cause NMD
a
Not for
NMD
b Total
Known pathological variants 8
c 08
Other nonsense SNPs 573 602 1175
Total 581 602 1183
aThis prediction is based on that mRNA would be destroyed if a stop codon
occurs in the 59 side of the boundary, which is 50–55 nucleotides upstream
from the 39 end of the second to last exon. Here, the nonsense SNPs located in
the 59 side of the boundary, which was set at 50 nucleotides upstream from
the 39 end of the second to last exon, were predicted to cause NMD.
bThis number includes SNPs in genes consisting of only one exon.
cP=0.0033 by Fisher’s exact test.
doi:10.1371/journal.pone.0003393.t006
Table 7. Nonsense SNPs with known pathological effects.
Acc# Chr Gene symbol SNP Variation OMIM Biological effects
M60092 1 AMPD1 rs17602729 Gln12Ter 102770 AMPD deficiency
M12272 4 ADH1C rs283413 Gly78Ter 103730 Parkinson disease
BC073741 7 PGAM2 rs10250779 Trp78Ter 261670 Myopathy
AF000571 11 KCNQ1 rs17215500 Arg518Ter 607542 Long QT syndrome 1
AY358222 11 CASP12 rs497116 Arg125Ter 608633 Sepsis susceptibility
M86407 11 ACTN3 rs2228325 Arg577Ter 102574 Athletic performance
L41870 13 RB1 rs3092891 Arg445Ter 180200 Bilateral retinoblastoma
AF068760 15 BUB1B rs28989186 Arg194Ter 602860 Premature chromatid separation trait and
mosaic variegated aneuploidy syndrome
doi:10.1371/journal.pone.0003393.t007
Table 8. Functional bias of genes having nonsense SNPs causing NMD.
Top level Gene Ontology no. Gene Ontology
Observed
gene no.
a
Expected
gene no.
b
Ratio of
enrichment P value
c
Biological process 0006118 electron transport 15 4.23 3.55 5.03610
25
0006468 protein amino acid phosphorylation 16 7.28 2.20 4.98610
23
Cellular component 0016020 membrane 41 22.55 1.82 5.57610
24
0005578 proteinaceous extracellular matrix 8 1.21 6.62 2.17610
26
Molecular function 0005524 ATP binding 35 17.15 2.04 1.79610
24
0004713 protein tyrosine kinase activity 16 6.46 2.48 1.56610
23
0004674 protein serine/threonine kinase activity 16 6.78 2.36 2.51610
23
0000166 nucleotide binding 14 5.61 2.50 2.79610
23
0004672 protein kinase activity 16 7.15 2.24 4.21610
23
0003723 RNA binding 10 3.11 3.22 1.82610
23
0005506 iron ion binding 8 2.00 4.00 1.32610
23
0005509 calcium ion binding 16 7.65 2.09 7.89610
23
0005215 transporter activity 10 3.44 2.91 3.76610
23
0016491 oxidoreductase activity 11 4.24 2.59 5.76610
23
0003779 actin binding 6 1.27 4.74 2.24610
23
0004759 carboxylesterase activity 5 0.24 20.44 4.19610
26
aNumber of genes with a molecular function in the 581 genes in which nonsense SNPs causing NMD were found.
bExpected number of genes that have a biological function in a sample of 581 genes, assuming a proportion of genes with a molecular function in all human genes.
cEnrichment of a biological term in the genes for nonsense SNPs was statistically evaluated as a upper probability in a hypergeometric distribution.
doi:10.1371/journal.pone.0003393.t008
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In this study, we conducted an extensive analysis of human
genome polymorphisms with a comprehensive catalogue of human
genes, and detected more than 50,000 polymorphisms that affect
proteins. The distribution of polymorphisms showed different
densities of polymorphisms among the 59UTR, ORF and 39UTR.
The density of SNPs was lower in ORFs than in the 59UTR and
39UTR. The density of synonymous SNPs in the ORFs was higher
than the densities of SNPs in the UTR regions. The reduction in
density of SNPs in the UTR regions is consistent that there are
functional constraints on nucleotide changes in UTRs related to the
transcriptional and translational efficiency[22]. The density of
nonsynonymous SNPs was much lower than the densities of other
types of SNPs, possibly due to that the nucleotide changes with
alteration of amino acidschanges are under strong negative selection
[36]. It was not known how nonsense SNPs are distributed in
protein-coding regions. Here we showed that the density of nonsense
SNPs is much lower than that of nonsynonymous SNPs. Although
the biological effects of nonsense mutations appear to vary widely
depending on their positions and the genes, the low density of
nonsense SNPs that we found suggests that nonsense mutations have
more disadvantageous effects than nonsynonymous mutations.
While nonsense mutations that cause NMD result in ‘loss of
function’, nonsense mutations that do not cause NMD produce
truncated proteins which could have the dominant effects. The
proportion of predicted nonsense SNPs causing NMD in this study
is in agreement with a previous study which showed that dbSNP
(build 125) has 1301 nonsense SNPs, about half of which were
predicted to result in NMD [37]. In order to understand the
biological effects of nonsense SNPs, it is important to know
whether they do or do not cause NMD, because premature stop
codons in a gene can have distinct disease phenotypes depending
on the positions of mutations [27,38].
The molecular functions that were overrepresented in the genes
having nonsense SNPs included several molecular functions that
were observed in human-specific pseudogenes[39], such as ATP
binding, actin binding, calcium ion binding, extracellular matrix,
nucleic acid binding and oxidoreductase. This is in accord with that
nonsense mutations contribute to ‘pseudogenization’. It is interesting
that nonsense SNPs causing NMD were frequently found in genes
that encode proteins involved in phosphorylation, cell-cell interac-
tion,signaltransductionandtransport.Thismaybebecausechanges
in the length of polypeptides caused by nonsense mutations are
under strong negative selection in the genes involved in signal
transduction or transportation because abnormal translation
products could cause dominant effects. Therefore, inactivation of
translation by nonsense mutations in those genes could have milder
effects than changes of the length of polypeptides.
Our results showed a low proportion of matches of nonsense
SNPs with known pathological variants in OMIM, suggesting that
the effects of most nonsense polymorphisms are unknown or not
reported. Furthermore, the correspondence of the nonsense SNPs
to the OMIM allelic variants (Table 6, Table 7) suggests that
nonsense polymorphisms that are subject to NMD are more likely
to be involved in phenotypic variations.
There is a possibility that the nonsense SNPs detected here have
pathological effects, in particular, if non-dispensable genes have
nonsense mutations. First, a defect in one gene by a nonsense
mutation or a frame-shifting indels causing a premature
termination codon could be a cause of genetic diseases including
complex diseases[40]. Second, there is a possibility that nonsense
mutations cause recessive lethal alleles that would not be detected
as causative variant of diseases. Probably, focusing on nonsense
polymorphisms observed in specific populations would be a good
way of selection for finding variants with deleterious effects.
The effect of single nonsense SNPs can be compensated by the
products of other genes having similar functions[41] and the other
splicing isoforms of the gene [42]. Thus, single nonsense SNPs may
not always cause severe phenotypic effects. In fact, some nonsense
SNPswithhighallelefrequencieswerefound acrosspopulations[43].
There is a report of fixation of an inactive form of caspase 12 by a
nonsense mutation (rs497116) in non-African populations[43], and
this is an example supporting the ‘less is more hypothesis’[44]. This
example suggests that some of nonsense mutations are not
disadvantageous and that the increase of frequency of a nonsense
allele could be driven by positive selection.
Elongation of polypeptides by read-through mutations can
affect protein folding and aggregation of proteins, which could
affect phenotypic variations. Furthermore, a read-through muta-
tion can cause more severe effects on translation when no
additional stop codon follows. Such mutations are subject to ‘non-
stop decay’ [32,33], and would result in no gene product. It has
been suggested that non-stop decay and NMD serve to remove
toxic, aberrant proteins [29]. It is unclear how frequently such
mutations prevent mRNA from producing proteins. Therefore, it
would be quite useful to be able to predict the effects of various
types of genetic changes on mRNA.
Although the present results are based on representative
transcripts (one transcript for one gene), the total number of
Table 9. Functional bias of genes having nonsense SNPs not causing NMD.
Top level
Gene Ontology
no. Gene Ontology
Observed
gene no.
a
Expected
gene no.
b
Ratio of
enrichment P value
c
Biological process 0007156 homophilic cell adhesion 6 1.42 4.23 3.05610
23
0006310 DNA recombination 3 0.19 15.50 8.25610
24
0006414 translational elongation 3 0.34 8.85 4.48610
23
0042254 ribosome biogenesis and assembly 2 0.15 13.77 8.68610
23
Cellular component 0005853 eukaryotic translation elongation factor 1 complex 2 0.13 15.50 6.82610
23
Molecular function 0004194 pepsin A activity 2 0.18 11.27 1.30610
22
0003746 translation elongation factor activity 2 0.29 6.89 3.35610
22
aNumber of genes with a molecular function in the 602 genes in which nonsense SNPs causing NMD were found.
bExpected number of genes that have a biological function in a sample of 602 genes, assuming a proportion of genes with a molecular function in all human genes.
cEnrichment of a biological term in the genes for nonsense SNPs was statistically evaluated as a upper probability in a hypergeometric distribution.
doi:10.1371/journal.pone.0003393.t009
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the splicing isoforms was much larger (2,234). These variations,
which cause changes in the length of a polypeptide or which
determine whether a protein is translated, may include patholog-
ical variants that have yet not been reported. Therefore, it is
important to examine their presence in human populations.
Materials and Methods
Data of human genetic polymorphisms
As data of genetic polymorphisms of human genome, single
nucleotide polymorphisms (SNPs) and insertions and deletions
(indels) in dbSNP [1] were used in this study. The whole data of
human SNPs and indels were downloaded from dbSNP (build
125). We used all SNPs and indels that were mapped on single
position in the genome, except for ‘large insertions’ in dbSNP.
Data of human genes
The data of human gene structure were obtained from H-InvDB
ver3.8 (http://www.h-invitational.jp/), created by the annotation
projectofhumangenes(H-Invitationalproject)[23,45].Ouranalysis
of all human genes that corresponds to H-InvDB (ver 3.8) predicted
36,712 protein coding loci. All protein-coding genes were annotated
and classified based on similarity to known genes as follows;
Category I, Identical to known human protein; Category II, Similar
to known protein; Category III, IPR domain containing protein;
Category IV, Conserved hypothetical protein; Category V,
Hypothetical protein; Category VI, Hypothetical short protein;
Category VII, pseudogene candidate. We used the following three
kinds of data of the gene structure: 1) genomic location of exons to
the human genome (build 35), 2) predicted ORF regions in
transcripts, and 3) original and curated cDNA sequences.
Analysis
1. Analysis of polymorphism with exons and predicted
ORFs. Selection of polymorphisms on exon regions. We
selected polymorphisms in exon regions by comparing the
genomic positions of polymorphisms and the start and end
positions of exons that were obtained from mapping cDNA
sequences to the human genome (Figure 1). Polymorphisms in
introns were also selected in a same way.
Conversion of genomic position of polymorphism into
nucleotide position in cDNA sequence. To analyze
polymorphisms with a predicted ORF, nucleotide positions of
polymorphisms in the human genome sequences were converted
into the nucleotide positions in cDNA sequences. Because there
could be gaps in the alignment of cDNA sequence and the human
genome sequence, the nucleotide position was converted consid-
ering possible gaps in the alignment. When the cDNA sequence
was corrected in ORF prediction because of frame-shifting and
remaining intron, the nucleotide position of SNP was modified
based on addition or deletion of nucleotides. For a quality control
of polymorphism data used for classification, we conformed that
one of the nucleotides in each pair of SNP alleles was the same
nucleotide at the corresponding position in the cDNA sequence.
Classification of polymorphisms with predicted ORF.
Polymorphisms within ORF were classified according to their effect
on ORF. For SNPs with two alleles, alleles in nucleotide were
converted into ‘alleles in codon’ by adding two other nucleotides in
the codon from cDNA sequence. When a cDNA sequence was
corrected in the annotation process by removing a remaining intron
or by correcting a frameshift error, the corrected cDNA sequence
was used. If these alleles in codon do not contain any stop codon, the
alleles were classified into synonymous and nonsynonymous. In case
a stop codon is included in the alleles in codon, they were classified
into 1) premature termination (nonsense) codon, 2) read-through of
original stop codon, and 3) synonymous at stop codon site, by
assuming that the cDNA sequence has an ancestral allele. Indels
wereclassifiedbasedonwhethertheyarelocatedinORF.Theindels
within ORF were further classified by whether the insertion or
deletion causes frame shifting in translation.
Inference of direction of nonsense and read-through
mutations.Ancestral alleles were obtained from dbSNP (build 128)
to check direction of mutations for SNPs causing changes between
amino acids and stop codons. For nonsense SNPs in protein-coding
regions, we checked whether the ancestral allele codes amino acids.
In case that the ancestral allele codes stop codon, we do not regard
this SNP as nonsense SNP, but is a read-through mutation assuming
that there was a variant having a shorter ORF. For read-though
SNPs at termination codon site, we checked whether the ancestral
allele codes stop codon. In case that the ancestral allele codes amino
acids, we regard this SNP not as a read-through mutation, but as a
nonsense mutation in a variant having a longer ORF.
Number of sites for synonymous, nonsynonymous and
nonsense mutations. To estimate densities of synonymous,
nonsynonymous and nonsense SNPs, the numbers of potential
synonymous, nonsynonymous and nonsense sites by single nucleotide
changes were estimated for the ORF sequences. This is an extension
of estimation of the numbers of synonymous and nonsynonymous
sites[46]; the number of synonymous sites is calculated as the number
of four-fold degenerate sites plus one-third of the number of two-fold
degenerate sites. For 61 codons encoding amino acids, the numbers
of nucleotide sites that would cause synonymous, nonsynonymous
a n dn o n s e n s emu t a t i o n sb yas i n g l en u c le o t i d ech a n g ew e r ee st im a t e d
with a model of nucleotide change. Here, the relative occurrence of a
transitional mutation versus a transversional mutation (r)w a ss e tt ob e
4.0 (the expected ratio in the numbers of transitional and
transversional mutations was 2.0). For example of the TTA codon
for leucine, the number of nonsense sites was estimated to be 2.0/
(r+2.0), because two types of transversional mutations at the second
position cause nonsense mutations.
2. Correspondence to known pathological variants. To
check whether the polymorphisms that alter proteins are known
pathological variants with phenotypic effect, we examined
correspondence of SNPs with data of known pathological variants.
Weused dataof‘allelicvariant’inthe Online MendelianInheritance
in Man (OMIM) database [18] as information of variants with
phenotypic effect. For nonsynonymous and nonsense SNPs, their
effects on translation and positions in ORF were compared with the
‘list of alleles’ in OMIM (e.g. described as ‘‘TRP324TER’’ or
‘‘ALA279THR’’ for the NGAS gene).
3. Prediction of nonsense SNPs causing NMD. Some of
nonsense mutations cause nonsense-mediated decay (NMD),
resulting in prevention of translation. It has been reported that
mRNA would be destroyed if a stop codon occurs in the 59 side of
the boundary, which is 50–55 nucleotides upstream from the end
of the second to last exon [30,31]. To predict whether a nonsense
SNP causes NMD, we examined whether a nonsense SNP is
located in the 39 side of the boundary, which was set at 50
nucleotides upstream from the end of the second to last exon, in
the exon-intron structure. This method is the same as the method
in SNP2NMD [37] when ‘NMD distance’ is 50 nucleotides.
5. Functional bias of genes with nonsense SNPs. For
each biological term from Gene Ontology (www.geneontology.
org), a proportion of genes with the biological function in the genes
having nonsense SNPs was compared with that in all human genes
(representative transcripts in all human genes in H-InvDB ver 5.0),
and the significance of over representation of a molecular function
Distribution of Nonsense SNPs
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probability of the hypergeometric distribution.
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